UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial

Journal of clinical oncology, 2018-03, Vol.36 (9), p.875-883

2018

Volltextzugriff (PDF)

Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4373-4380

2011

Volltextzugriff (PDF)

Aerobic and Resistance Exercise Improves Shoulder Function in Women Who Are Overweight or Obese and Have Breast Cancer: A Randomized Controlled Trial

Physical therapy, 2019-10, Vol.99 (10), p.1334-1345

2019

Volltextzugriff (PDF)

Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients

Frontiers in oncology, 2013-01, Vol.3, p.298-298

2013

Volltextzugriff (PDF)

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Clinical cancer research, 2007-01, Vol.13 (2), p.654-658

2007

Volltextzugriff (PDF)

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

BioMed research international, 2015-01, Vol.2015 (2015), p.1-9

2015

Volltextzugriff (PDF)

Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast

Breast cancer research and treatment, 2009-11, Vol.118 (1), p.161-168

2009

Volltextzugriff (PDF)

Reversal of Gonadotropin-releasing Hormone Agonist Induced Reductions in Mammographic Densities on Stopping Treatment

Cancer epidemiology, biomarkers & prevention, 2001-11, Vol.10 (11), p.1117-1120

2001

Volltextzugriff (PDF)

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation

Breast cancer research and treatment, 2012-04, Vol.132 (2), p.653-660

2012

Volltextzugriff (PDF)

Decreasing time to initiation of inpatient chemotherapy at LAC+USC medical center utilizing an admission checklist

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.262-262

2019

Volltextzugriff (PDF)

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

Contraception (Stoneham), 2012-09, Vol.86 (3), p.238-243

2012

Volltextzugriff (PDF)

Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

Epidemiologic reviews, 1993, Vol.15 (1), p.17-30

1993

Volltextzugriff (PDF)

Mammographic Density Changes During the Menstrual Cycle

Cancer epidemiology, biomarkers & prevention, 2001-02, Vol.10 (2), p.141-142

2001

Volltextzugriff (PDF)

Measuring the long commute: Experiences of a multi-ethnic cohort of patients enrolled in a financial reimbursement program for cancer clinical trials

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18568-e18568

2022

Volltextzugriff (PDF)

Utilization of a multisite financial reimbursement program to promote racial/ethnic diversity and inclusion in therapeutic cancer clinical trials: The iMPACT Study

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.85-85

2020

Volltextzugriff (PDF)

A phase 1 trial in progress for in situ immunomodulation with CDX-301, radiation therapy, poly-ICLC, and CDX-1140 in patients with unresectable and metastatic solid tumors

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.TPS2697-TPS2697

2024

Volltextzugriff (PDF)

Is there a role for 21-gene recurrence score in mucinous carcinoma of breast?

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e12538-e12538

2018

Volltextzugriff (PDF)

Phase II trial of metronomic capecitabine and cyclophosphamide with lapatinib and trastuzumab in patients with HER2-positive metastatic breast cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e12508-e12508

2019

Volltextzugriff (PDF)

Comprehensive characterization of androgen receptor expression in breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1035-1035

2023

Volltextzugriff (PDF)

Changes in Mammographic Densities Induced by a Hormonal Contraceptive Designed to Reduce Breast Cancer Risk

JNCI : Journal of the National Cancer Institute, 1994-03, Vol.86 (6), p.431-436

1994

Volltextzugriff (PDF)

Molecular characterization of the Ras-MAPK pathway in metastatic breast cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1034-1034

2021

Volltextzugriff (PDF)

Review of next generation sequencing outcomes in patients with metastatic breast cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12558-e12558

2017

Volltextzugriff (PDF)

Abstract 3262: Biomarkers of response to deslorelin in women at high risk of breast cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3262-3262

2018

Volltextzugriff (PDF)

Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12554-e12554

2017

Volltextzugriff (PDF)

Can Mammographic Densities Predict Effects of Tamoxifen on the Breast?

JNCI : Journal of the National Cancer Institute, 1996-01, Vol.88 (2), p.128-129

1996

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Humans
(32)
Female
(31)
Oncology
(23)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Adult
(19)
Middle Aged
(15)
Breast Neoplasms - Prevention & Control
(13)
Pharmacology. Drug Treatments
(11)
Breast Cancer
(10)
Gynecology. Andrology. Obstetrics
(10)
Antineoplastic Agents
(8)
Mammary Gland Diseases
(7)
Tumors
(7)
Aged
(6)
Breast Neoplasms - Epidemiology
(6)
Chemotherapy
(5)
Mammography
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial

Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women

Aerobic and Resistance Exercise Improves Shoulder Function in Women Who Are Overweight or Obese and Have Breast Cancer: A Randomized Controlled Trial

Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast

Reversal of Gonadotropin-releasing Hormone Agonist Induced Reductions in Mammographic Densities on Stopping Treatment

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation

Decreasing time to initiation of inpatient chemotherapy at LAC+USC medical center utilizing an admission checklist

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

Mammographic Density Changes During the Menstrual Cycle

Measuring the long commute: Experiences of a multi-ethnic cohort of patients enrolled in a financial reimbursement program for cancer clinical trials

Utilization of a multisite financial reimbursement program to promote racial/ethnic diversity and inclusion in therapeutic cancer clinical trials: The iMPACT Study

A phase 1 trial in progress for in situ immunomodulation with CDX-301, radiation therapy, poly-ICLC, and CDX-1140 in patients with unresectable and metastatic solid tumors

Is there a role for 21-gene recurrence score in mucinous carcinoma of breast?

Phase II trial of metronomic capecitabine and cyclophosphamide with lapatinib and trastuzumab in patients with HER2-positive metastatic breast cancer

Comprehensive characterization of androgen receptor expression in breast cancer

Changes in Mammographic Densities Induced by a Hormonal Contraceptive Designed to Reduce Breast Cancer Risk

Molecular characterization of the Ras-MAPK pathway in metastatic breast cancer

Review of next generation sequencing outcomes in patients with metastatic breast cancer

Abstract 3262: Biomarkers of response to deslorelin in women at high risk of breast cancer

Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib

Can Mammographic Densities Predict Effects of Tamoxifen on the Breast?

Suchergebnisse filtern